ReviewCancers2023

Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy.

Clifton C Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.